TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06043843

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Focused diabetes tele-education and medication adjustment based on guidelines with remote monitoring from trial of fasting from before to throughout Ram
Description: 1. Ramadan-focused online education by physician, specialist nurse, and dietitian via video conferencing~   1. Fasting and exemptions~  2. Self-monitoring of blood glucose~  3. Acute diabetes complications and treatment~  4. Ramadan nutritional plan~  5. Safe physical activity You will be taught to record~   <!-- -->~   1. Meal plans~  2. Physical activities~  3. Blood glucose monitoring, and~  4. Monitoring for diabetes complications Perform a trial fasting day prior to Ramadan.~2. Medication adjustments will be made according to the Diabetes and Ramadan Alliance guideline as well as individualized modifications based on their HbA1c as follows Baseline HbA1c Recommended dose reduction \< 8% 30% 8 to 10% 15% \> 10% None~2) Glucose monitoring~1. up to 4 times daily Before Ramadan for 1 week During Ramadan After Ramadan for 1 week~2. uploaded into an online portal for data collection, without remote monitoring.
Study: NCT04505501

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-803
Description: N-803 is a novel IL-15 superagonist complex that enhances NK cell and CD8+ T-cell proliferation and activation.
Study: NCT05993013

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LudoFit
Description: Game-based, technology-enabled home exercise software, done at least 3 times per week. Video games for a variety of exercises that promote balance, strength, endurance, and coordination.
Study: NCT04751734

Intervention type: BIOLOGICAL
Intervention: Covid vaccines
Description: women within Priority groups for coronavirus (COVID-19) vaccination
Study: NCT04773470

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Flexible Endoscopic Evaluation of Swallowing
Description: Endoscopical swallowing study
Study: NCT05697419

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: deep breathing, muscle relaxation, and mindfulness
Description: 5-10-minute group sessions will be administered to DPT students teaching them the NIH recommended strategies of deep breathing, muscle relaxation or mindfulness.
Study: NCT06162793

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RehaPlus+
Description: 24-week eHealth intervention
Study: NCT06443658

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Description: Patients from intervention group will inhale hypertonic saline solution 5 minutes before performing the morning ELTGOL technique
Study: NCT04272632

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4 ml/kg group
Description: 4 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 8 ml/kg group
Description: 8 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 12 ml/kg group
Description: 12 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.
Study: NCT04776525

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ifosfamide
Description: 3 g/m2 each day for three days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: 80 mg/m2 over four hours day 1
Study: NCT06443658

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline
Description: Patients from placebo group will inhale isotonic saline solution 5 minutes before performing the morning ELTGOL technique

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ELTGOL
Description: Patients from control group will perform the ELTGOL technique twice-daily
Study: NCT05354479

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Description: babies will get expressed breast milk along with paracatamol for pain relief

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: babies will get expressed breast milk along with paracatamol for pain relief
Study: NCT05397093

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ITIL-306
Description: ITIL-306 is a cell therapy product derived from a participant's own TILs and contains a unique molecule designed to increase TIL activity when it encounters FOLR1 on the tumor. A portion of the participant's tumor is surgically removed to make a personalized ITIL-306 product. Once ITIL-306 has been made, the participant is treated with 3 days of lymphodepleting chemotherapy including cyclophosphamide and fludarabine, followed by 2 days of rest then a single infusion of ITIL-306.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ITIL-306
Description: ITIL-306 is a cell therapy product derived from a participant's own TILs and contains a unique molecule designed to increase TIL activity when it encounters FOLR1 on the tumor. A portion of the participant's tumor is surgically removed to make a personalized ITIL-306 product. Once ITIL-306 has been made, the participant is treated with 3 days of lymphodepleting chemotherapy including cyclophosphamide and fludarabine, followed by 2 days of rest then a single infusion of ITIL-306.
Study: NCT06443658

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: ELTGOL
Description: Patients from control group will perform the ELTGOL technique twice-daily

Intervention type: OTHER
Group type: OTHER
Intervention: ELTGOL
Description: Patients from control group will perform the ELTGOL technique twice-daily
Study: NCT04987359

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multimodal Lifestyle Program
Description: The multimodal lifestyle program will utilize intensive behavioral therapy with structured exercise training and nutritional counseling.
Study: NCT06491134

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal Irinotecan Hydrochloride
Description: liposomal irinotecan With Cisplatin and Concurrent Radiotherapy
Study: NCT05407792

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Staphylococcus and Neisseria Tablets
Description: 0.3 mg/ tablet, 4 tablets each time, 3 times a day (Shandong Qilu Pharmaceutical Co., LTD.), the course of treatment was more than 3 months.

Intervention type: OTHER
Group type: OTHER
Intervention: On-demand treatment
Description: At the time of enrollment, patients with acute exacerbation of bronchiectasis were given routine treatment. For patients with stable bronchiectasis at the time of enrollment, they are treated as needed (that is, according to the needs of the disease, receive corresponding treatment).
Study: NCT04899583

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sirolimus Coated Balloon Catheter
Description: a Sirolimus Coated Balloon Catheter designed and produced by Acotec

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: a Paclitaxel Coated Balloon Catheter
Description: a Paclitaxel Coated Balloon Catheter(trade name:Bingo)
Study: NCT05359107

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Free From Pain Exercise Book
Description: Contains educational information and exercises to improve musculoskeletal pain and reduce sarcopenia.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The Back Book
Description: Contains advice and guidance on how to deal with and reduce back pain.
Study: NCT05698290

Intervention type: OTHER
Intervention: HELP Pain Training Program
Description: A training program to teach school providers nonpharmacologic (e.g., cognitive behavioral and mindfulness meditation) strategies to use with students with pain symptoms.

Intervention type: OTHER
Intervention: HELP Pain Training Program
Description: A training program to teach school providers nonpharmacologic (e.g., cognitive behavioral and mindfulness meditation) strategies to use with students with pain symptoms.
Study: NCT05360550

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSP-5415
Description: pregnancy prevention
Study: NCT05485207

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Transvaginal botulinum toxin A (BTA) injection
Description: Botulinum toxin A (Botox® 100 units) will be injected into the detrusor muscle of the bladder by inserting a needle through the anterior vaginal wall.
Study: NCT05068856

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS2543
Description: Dose-escalation part For the dose-escalation study, five dose cohorts (25 mg , 75 mg , 150 mg , 300 mg , and 450 mg ) of HRS2543 are initially set.~Dose-expansion part After the completion of dose-escalation study, the dose-expansion study will be carried out at the recommended dose level by the SMC.
Study: NCT06330909

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) Arm A - IMRT/IGRT/SBRT
Description: technique: IMRT/IGRT/SBRT~The HypoFocal-SBRT study combines ultra-hypofractionated RT / stereotactic body RT (reduction of treatment time) with a focal RT dose escalation on intraprostatic tumor sides by applying state of the art diagnostic imaging and most modern RT concepts.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy (RT) Arm B - IMRT/IGRT
Description: technique: IMRT/IGRT~Moderate hypofractionated RT (MHRT), one option for the curative primary treatment of PCa, which has been proven by several prospective trials and is recommended and carried out worldwide.
Study: NCT04104126

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Physical Therapy
Description: Will receive standard of care physical therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood flow restriction
Description: Blood flow restriction therapy is a blood pressure cuff placed around the desired limb with a handheld device that controls the pressure exerted by the cuff. The cuff is placed around the desired limb before a specific exercise, the physical therapist determines the appropriate pressure and time, and the patient completes the exercise as they normally would. The monitor determines the limb occlusion pressure and has an automatic timer that will deflate after the specified time has elapsed.
Study: NCT05614934

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: standard Clarithromycin triple therapy
Description: Oral administration of proton pump inhibitor standard or double dose twice daily, clarithromycin 500 mg twice daily and, Amoxicillin1g twice daily for 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan triple therapy
Description: Oral administration of Vonoprazan 20mg twice daily, clarithromycin 500 mg twice daily, and, Amoxicillin1g twice daily for 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan dual therapy
Description: Oral administration of Vonoprazan 20mg twice daily and, Amoxicillin1g three times daily for 14 days
Study: NCT05910671

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Phone Calls and Notebook
Description: This intervention encouraged parents to model physical activity behaviors and co-participate in physical activity with their young child. Each week behavioral strategies for promoting physical activity change will be discussed to help parents work towards meeting their activity goals. As part of the physical activity intervention parents will receive a physical activity notebook that has newsletters, suggested activities that can be done with their child, and other material that will help the parent and child be active active together. The behavioral strategies and the information in the notebook will will be discussed weekly for 30 minutes via telephone.
Study: NCT05302635

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulated group
Description: Students will be given training on nasogastic tube insertion and practice will be demonstrated in the laboratory based on the demonstration method and checklists, and will continue until students learn. Forms will be applied to students as a pre-test. A pilot scenario will be applied to two volunteer fourth year students.~Prebriefing: Students will be informed. Students will implement the scenario in the simulation laboratory and will wear uniforms. The student will be given 5 minutes for preparation, the application will be taken one by one and 15 minutes will be given for practice. Researchers will only observe during this time. During the application, the student will be scored according to the checklist. Students will be recorded with video.~Debriefing: Immediately after the end of the scenario, a debriefing session will be held with groups of 5 people. Feedback will be given on students' performance. Each session will last 20-30 minutes. Students will be given a post-test.
Study: NCT05307458

Intervention type: DRUG
Intervention: Buprenorphine/naloxone
Description: Participants will receive gradually increasing doses of buprenorphine while tapering down on their methadone dose.
Study: NCT06184438

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction(Daflon 1000mg)
Description: Received Micronized purified flavonoid fraction(Daflon 1000mg) BID after surgery from day to day 7

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Received placebo after surgery.
Study: NCT04499170

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscular Energy Technique G1
Description: Group of older (G1) - The muscular energy technique (TEM) based on Chaitow's proposal will be applied to the postural posterior muscles of the lower limbs such as gastrocnemius, soleus, ischiostibials, gluteus medius and paravertebral. During TEM, the contraction will be maintained from 7 to 10 seconds, against the resistance imposed by the therapist. After relaxation, range of motion will be gained until your new restriction barrier. This process will be repeated for 3 times.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Muscular Energy Technique G2
Description: Group of young people (G2) - The muscular energy technique (TEM) based on Chaitow's proposal will be applied to the postural posterior muscles of the lower limbs such as gastrocnemius, soleus, ischiostibials, gluteus medius and paravertebral. During TEM, the contraction will be maintained from 7 to 10 seconds, against the resistance imposed by the therapist. After relaxation, range of motion will be gained until your new restriction barrier. This process will be repeated for 3 times.
Study: NCT03313622

Intervention type: BEHAVIORAL
Intervention: Beads Task
Description: Participants will be asked to make a series of decisions that involve combining information about the value and probability of potential rewards. Subjects will sit in front of a computer monitor and place their hand over a box with orange and blue button that they will be asked to press based on their idea of which one will be the majority in a jar full of orange and blue beads. This task should take 15-20 minutes to complete, not including EEG setup.

Intervention type: BEHAVIORAL
Intervention: PROVOC Tasks
Description: Three tasks will be developed collaboratively with the participant and independent evaluator that involve the participant being exposed to triggers that are considered by him/her impossible to confront without ritualizing. There will also be a similar process involving objects that should not cause any distress to be used as a control. Sessions will be videotaped with AFAR system concurrent to recording of LFPs from VS and scalp EEG.
Study: NCT05343078

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10Mg Tab
Description: Participants will take a single-dose Dapagliflozin 10mg P.O. prior to the hemodialysis session for the single-dose pharmacokinetics protocol. In the multiple-dose protocol, Dapagliflozin 10mg P.O. will be taken daily in the morning for one week.
Study: NCT04967794

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Teleorientation and Tooth Brushing Orientation
Description: Guide children in toothbrushing with a preventive purpose during the COVID-19 pandemic

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Teleorientation and Tooth Brushing Orientation
Description: Guide children in toothbrushing with a preventive purpose during the COVID-19 pandemic

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Teleorientation and Tooth Brushing Orientation
Description: Guide children in toothbrushing with a preventive purpose during the COVID-19 pandemic
Study: NCT06132074

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School sessions on consent, reciprocity and sexual violence
Description: The intervention consists of a 120-minute workshop led by a representative from Uppsala Tjej- och Transjour and aims to reduce the vulnerability and prevalence of sexual harassment, sexual violence and to counteract men's violence against women and violence in close relationships by raising awareness among pupils, school staff and guardians about sexual health among young people. The workshop covers areas of consent, reciprocity and sexual violence. The participants will do several valuation based and discussion based exercises regarding these topics and discuss issues, legality, and norms during the time.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: School sessions on consent, reciprocity and sexual violence
Description: The intervention consists of a 120-minute workshop led by a representative from Uppsala Tjej- och Transjour and aims to reduce the vulnerability and prevalence of sexual harassment, sexual violence and to counteract men's violence against women and violence in close relationships by raising awareness among pupils, school staff and guardians about sexual health among young people. The workshop covers areas of consent, reciprocity and sexual violence. The participants will do several valuation based and discussion based exercises regarding these topics and discuss issues, legality, and norms during the time.
Study: NCT05814926

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GP681
Description: GP681, tablet, oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GP681
Description: GP681, tablet, oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GP681
Description: GP681, tablet, oral
Study: NCT05811689

Intervention type: DIAGNOSTIC_TEST
Intervention: sm tbs group
Description: After collecting anthropometric data, information on environmental factors and lifestyle (smoking, alcohol intake, physical activity, sun exposure, vitamin D supplementation, fish consumption) will be acquired through a questionnaire.~The genetic and environmental aspects related to multiple sclerosis will also be studied. Disability status will be assessed through the Kurtzke Extended Disability Status Scale (EDSS). \[10\] All recruited patients will be administered the questionnaire (Multiple Sclerosis Quality of Life-54 (MSQOL-54) composed of 14 scales and 54 items. The scales investigate physical functions, limitations with respect to physical and emotional role, pain, emotional well-being, degree of energy, perceptions of one's health, social, cognitive and sexual functioning, distress, changes in health, satisfaction with sexual functioning and quality of life in general.
Study: NCT05197322

Intervention type: DRUG
Group type: OTHER
Intervention: Pembrolizumab
Description: Dose: 200mg by IV infusion on Day 1 of each treatment cycle

Intervention type: DRUG
Group type: OTHER
Intervention: Pembrolizumab
Description: Dose: 200mg by IV infusion on Day 1 of each treatment cycle
Study: NCT04667494

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Sonotherapy
Description: Use of high mechanical index ultrasound therapy with intravenous Definity contrast infusion
Study: NCT04888819

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP14012
Description: DWP14012 40 mg, orally, once daily just after a meal up to 4 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP14012
Description: DWP14012 40 mg, orally, once daily before a meal up to 4 weeks
Study: NCT04784520

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HA121-28 tablets
Description: HA121-28 600 mg, po, QD×21 days, every 4 weeks (28 days)
Study: NCT04720664

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SM-88
Description: * SM-88, Two 230 mg capsules taken orally twice daily (920 mg daily).~* Methoxsalen, One 10 mg capsule taken orally once daily.~* Phenytoin, One 50 mg tablet taken orally once daily.~* Sirolimus, One 0.5 mg tablet taken orally once daily.
Study: NCT05994859

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SIRT
Description: The patients will receive 1-2 sessions of SIRT. If the patients have invasive tumors, extensive liver involvement or vascular invasion, systematic treatment will be added.
Study: NCT06254677

Intervention type: OTHER
Intervention: Retrospective review of histological features
Description: Correlate histopathology characteristics of acute kidney injury with molecular signatures, kidney function and aetiology of acute kidney injury to derive clinically validated scoring system for acute kidney injury and acute tubular injury

Intervention type: OTHER
Intervention: Retrospective review of histological features
Description: Correlate histopathology characteristics of acute kidney injury with molecular signatures, kidney function and aetiology of acute kidney injury to derive clinically validated scoring system for acute kidney injury and acute tubular injury

Intervention type: OTHER
Intervention: Retrospective review of histological features
Description: Correlate histopathology characteristics of acute kidney injury with molecular signatures, kidney function and aetiology of acute kidney injury to derive clinically validated scoring system for acute kidney injury and acute tubular injury